Inovio Pharmaceuticals Inc (NASDAQ: INO) stock suffered a major decline of -10.6% on 11/15/24. The shares closed at $4.26. Moreover, this decline was accompanied by exceptionally high trading volume at 206% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -22.7% during the last week.
Current PriceTarget Research Rating
Inovio Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Inovio Pharmaceuticals has a poor Appreciation Score of 28 and a very low Power Rating of 4, with the Lowest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment